Application of a rapid and efficient quantitative analysis method for traditional chinese medicines: The case study of quality assessment of salvia miltiorrhiza bunge

Molecules

Volumn 18, Issue 6, 2013, Pages 6919-6935

  Jing, Wen Guang ^a   Zhang, Jun ^a   Zhang, Li Yan ^b   Wang, Dong Zhe ^b   Wang, Yue Sheng ^a   Liu, An ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b GUIYANG COLLEGE OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

High performance liquid chromatography; Quality assessment; Quantitative analysis; Reference extractive; Salvia miltiorrhiza Bunge

Indexed keywords

HERBACEOUS AGENT; PLANT EXTRACT;

CHEMISTRY; CHINESE MEDICINE; DRUG STABILITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROCEDURES; REPRODUCIBILITY; SALVIA MILTIORRHIZA; STANDARD; STANDARDS; ARTICLE; METHODOLOGY;

CHROMATOGRAPHY, LIQUID; DRUG STABILITY; DRUGS, CHINESE HERBAL; MASS SPECTROMETRY; MEDICINE, CHINESE TRADITIONAL; PLANT EXTRACTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SALVIA MILTIORRHIZA;

EID: 84879656642     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18066919     Document Type: Article

References (28)

1. Dobos, G.J.; Tan, L.; Cohen, M.H.; McIntyre, M.; Bauer, R.; Li, X.; Bensoussan, A. Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country. Complement. Ther. Med. 2005, 13, 183-190.
2. Jiang, Y.; David, B.; Tu, P.F.; Barbin, Y. Recent analytical approaches in quality control of traditional Chinese medicines-a review. Anal. Chim. Acta 2010, 657, 9-18.
3. Li, F.M.; Xiong, Z.L.; Lu, X.M.; Qin, F.; Li, X.Q. Strategy and chromatographic technology of quality control for traditional chinese medicines. Chin. J. Chromatogr. 2006, 24, 537-545.
4. Xue, C.J.; Zhang, J.; Jing, W.G.; Wang, Y.S.; Si, N., Liu, A. Reference extractive determination of 5 components content of pueraria labta. Chin. J. Chin. Mater. Med. 2012, 37, 2388.
5. Cheng, T.O. Cardiovascular effects of Danshen. Int. J. Cardiol. 2007, 121, 9-22.
6. Oh, S.H.; Nan, J.X.; Sohn, D.H.; Kim, Y.C.; Lee, B.H. Salvia miltiorrhiza Inhibits Biliary Obstruction-Induced Hepatocyte Apoptosis by Cytoplasmic Sequestration of p53. Toxicol. Appl. Pharmacol. 2002, 182, 27-33.
7. Guo, J.X. Research and Clinical Application of the Root of Salvia Miltiorrhiza. Bunge; Chinese Medicine and Technology Press: Beijing, China, 1992; pp. 143-181.
8. Wu, W.L.; Zhu, Y.T.; Zhang, L.; Yang, R.W.; Zhou, Y.H. Extraction, preliminary structural characterization, and antioxidant activities of polysaccharides from Salvia miltiorrhiza Bunge. Carbohydr. Polym. 2012, 87, 1348-1353.
9. Zhou, L.M.; Zuo, Z.; Chow, M.S.S. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 2005, 45, 1345-1359.
10. Liu, J.; Shen, H.M.; Ong, C.N. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG2 cells. Cancer Lett. 2000, 153, 85-93.
11. Niu, X.L.; Lehimori, K.; Yang, X.; Hirota, Y.; Hoshiai, K.; Li, M.; Nakzawa, H. Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic. Res. 2002, 33, 305-312.
12. Gu, M.; Su, Z.G.; Ouyang, F. Fingerprinting of Salvia miltiorrhiza Bunge by thin-layer chromatography scan compared with high speed countercurrent chromatography. J. Liq. Chromatogr. Relat. Technol. 2006, 29, 1503-1514.
13. Ping, H.; Luo, G.A.; Zhao, Z.Z.; Jiang, Z.H. Quality Assessment of Radix Salviae. Miltiorrhizae. Chem. Pharm. Bull. 2005, 53, 481-486.
14. Gu, M.; Zhang, S.F.; Su, Z.G.; Chen, Y.; Ouyang, F. Fingerprinting of Salvia miltiorrhiza Bunge by non-aqueous capillary electrophoresis compared with high-speed counter-current chromatography. J. Chromatogr A 2004, 1057, 133-140.
15. Qu, H.B.; Zhai, X.J.; Shao, Q.; Cheng, Y.Y. Simultaneous determination of seven active compounds in radix salviae miltiorrhizae by temperature-controlled ultrasound-assisted extraction and HPLC. Chromatographia 2007, 66, 21-27.
16. Chang, Q.; Sun, L.; Zhao, R.H.; Chow, M.S.S.; Zuo, Z. Simultaneous determination of ten active components in traditional Chinese medicinal products containing both gegen (Pueraria iobata) and danshen (Salvia miltiorrhiza) by high-performance liquid chromatography. Phytochem. Anal. 2008, 19, 368-375.
17. Ma, H.L.; Qin, M.J.; Qi, L.W.; Wu, G.; Shu, P. Improved quality evaluation of Radix Salvia miltiorrhiza through simultaneous quantification of seven major active components by high-performance liquid chromatography and principal component analysis. Biomed. Chromatogr. 2007, 21, 931-939.
18. Ma, L.J.; Zhang, X.Z.; Zhang, H.P.; Gan, Y.R. Development and evaluation of an efficient HPLC/MS/MS method for the simultaneous determination of pseudoephedrine and cetirizine in human plasma: Application to Phase-I pharmacokinetic study. J. Chromatogr. B 2007, 846, 139-146.
19. Liu, M.; Li, Y.G.; Zhang, F.; Yang, L.; Chou, G.X.; Wang, Z.T.; Hu, Z.B. Chromatographic fingerprinting analysis of Danshen root (Salvia miltiorrhiza Radix et Rhizoma.) and its preparations using high performance liquid chromatography with diode array detection and electrospray mass spectrometry (HPLC-DAD-ESI/MS). J. Sep. Sci. 2007, 30, 2256-2267.
20. Cao, J.; Wei, Y.J.; Qi, L.W.; Li, P.; Qian, Z.M.; Luo, H.W.; Chen, J.; Zhao, J. Determination of fifteen bioactive components in Radix et Rhizoma. Salviae. Miltiorrhizae. by high-performance liquid chromatography with ultraviolet and mass spectrometric detection. Biomed. Chromatogr. 2008, 22, 164-172.
21. Liu, A.H.; Lin, Y.H.; Yang, M.; Guo, H.; Guan, S.H.; Sun, J.H.; Guo, D.A. Development of the fingerprints for the quality of the roots of Salvia miltiorrhiza and its related preparations by HPLC-DAD and LC-MSn. J. Chromatogr. B 2007, 846, 32-41.
22. Pharmacopoeia Commission of People's Republic of China. Pharmacopoeia of the People's Republic of China, 2010 ed.; Chemical Industry Press: Beijing, China, 2010; p. 71.
23. Chen, W.X.; Luo, Y.; Liu, L.; Zhou, H.Y.; Xu, B.S.; Han, X.Z.; Shen, T.; Liu, Z.; Lu, Y.; Huang, S. Cryptotanshinone inhibits cancer cell proliferation by suppressing mammalian target of rapamycin-mediated Cyclin D1 expression and Rb phosphorylation. Cancer Prev. Res. 2010, 3, 1015-1025.
24. Nizamutdinova, I.T.; Lee, G.W.; Lee, J.S.; Cho, M.K.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; et al. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 2008, 29, 1885-1892.
25. Zhang, X.X.; Chen, X.B.; Wang Y.P. Study on Technical Processes for Extraction and Purification of Total Tanshinones. J. Chin. Mater. Med. 2008, 31, 431-434.
26. Wu, W.Y.; Yang, Z.; Hou, J.J.; Guo, D.A. Study of comparison on different purify technologies of total tanshinones. J. Chin. Tradition. Herb Drugs 2008, 39, 1815-1817.
27. Dai, H.X.; Xu, Y.X.; Liu, Y.; Xiao, X.R.; Xue, M. Analysis of Cryptotanshinone by Electron Spray Ionization Mass Spectrometry and Electron Ionization Mass Spectrometry. J. Chin. Mass Spectrum. Soc. 2006, 27, 198-202.
28. Dai, H.X.; Xu, Y.X.; Liu, Y.; Xiao, X.R.; Xue, M. Elucidation of tanshinone IIA and tanshione I by electron spray ionization mass spectrometry and electron ionization mass spectrometry. Chin. J. Anal. Lab. 2008, 27, 24-29.